• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Zenotech Laboratories Ltd Pharmaceuticals - Indian - Formulations

  • Sun Pharma
  • BSE Code : 7341.0
  • ISIN : INE486F01012
51.92 0 (-0.54%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    51.51

  • Today’s High

    54.39

  • Open

    54.00

  • Perv Close

    52.20

  • 52W Low

    51.00

  • 52W High

    107.79

Key Indicators

  • P/E(TTM)

    81.13

  • Mar.Cap (₹Cr.)

    316.87

  • Div & Yield %

    0.00

  • Book Value(₹)

    15.27

  • Debt-Equity Ratio

    -0.54

  • AGM Date

    28-Mar-2025

  • EPS

    0.64

  • P/E Ratio

    81.13

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    316.87

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    61.03

  • BV (₹)

    15.30

  • Sales( ₹ in Cr.)

    40.83

  • NP (in Cr.)

    8.33

  • NP Var(%)

    -28.0

  • Div%

    0.0

  • CPS (₹)

    2.50

  • EPS (₹)

    1.40

  • Traded Value (₹ in Lakhs)

    316.87

  • 52 Week High

    107.79

  • 52 Week Low

    51.00

  • Price BSE

    52.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    316.87

  • P/C Ratio

    20.60

  • P/E Ratio

    38.10

  • Price Vs.BV

    1.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 40.83 42.42 36.57 22.45 26.02 13.03
Excise Duty 0.00 0.00 0.00 0.00 0.22 0.76
Net Sales 40.83 42.42 36.57 22.45 26.02 13.03
Other Income 1.00 1.08 0.63 0.41 1.17 4.71
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 41.84 43.51 37.19 22.85 27.19 17.74
EXPENDITURE :
Raw Materials 0.00 0.00 0.00 0.00 0.22 0.76
Power & Fuel Cost 0.00 0.00 0.00 0.00 0.22 0.76
Employee Cost 9.46 7.88 7.10 6.49 5.76 4.98
Other Manufacturing Expenses 0.43 0.31 0.19 0.13 0.12 0.32
Selling & Administrative Expenses 2.37 2.04 1.98 1.73 1.75 2.21
Miscellaneous Expenses 0.43 0.31 0.19 0.13 0.12 0.32
Less : Pre-operative Expenses Capitalised :
Total Expenditure 30.70 29.01 27.29 24.07 22.78 20.87
Operating Profit 11.35 11.43 9.84 7.68 8.91 8.32
Interest 0.00 0.11 1.22 1.55 0.89 0.12
Gross Profit 11.14 14.50 9.90 -1.22 10.78 -3.13
Depreciation 7.09 7.17 6.97 6.46 4.85 4.20
Profit Before Tax 11.14 14.50 9.90 -1.22 10.78 -3.13
Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 2.84 2.92 -12.27 0.00 0.00 0.00
Reported Net Profit 8.30 11.59 22.18 -1.22 10.78 -3.13
Extraordinary Items 11.14 14.50 9.90 -1.22 10.78 -3.13
Adjusted Net Profit 8.30 11.59 22.18 -1.22 10.78 -3.13
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 8.30 11.59 22.18 -1.22 10.78 -3.13
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.36 1.90 3.63 -0.20 1.77 -0.51
Book Value 0.00 0.00 0.00 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    68.84%

  • Public Share Holding

    31.16%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 42,014,578 68.84 42,014,578 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 42,014,578 68.84 42,014,578 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 600,000 0.98 600,000 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 4,364 0.01 4,364 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 604,364 0.99 604,364 2
2] Non Institution
Bodies Corporate 2,647,490 4.34 2,647,490 61
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 194,319 0.32 186,851 107
Foreign Non Institution Other 692,791 1.14 0 1
Hindu Undivided Families 943,363 1.55 943,363 288
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 9,222,089 15.11 4,128,851 55
Individuals holding nominal share capital up to Rs. 1 lakh 4,711,473 7.72 4,669,481 10,151
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 101 0.00 100 1
Sub Total 18,411,626 30.17 12,576,136 10,664
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 61,030,568 100.00 55,195,078 10,667

Company Background

Zenotech Laboratories LtdPharmaceuticals - Indian - Formulations

  • Zenotech Laboratories Ltd
  • BSE Code : 7341.0
  • ISIN : INE486F01012

  • Incorporation Year

    1989

  • Registered Office

    S No 250-252 Turkapally Villag
    Shameerpet Mandal RR District, Hyderabad,
    Telangana-500078

  • Telephone

    91-40-23480430/0435

  • FAX

    91-40-23480429

  • Chairman

    Azadar Hussain Khan

  • Managing Director

  • Company Secretary

    Abdul Gafoor Mohammad

  • Auditor

    PKF Sridhar & Santhanam LLP

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Zenotech Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Zenotech Lab. 51.92 41.84 40.83 63.32 4.09
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92